 - Participants must have steroid-refractory cGVHD, which is defined as having persistent signs and symptoms of cGVHD despite the use of prednisone at 0.25 mgkgday or 0.5 mgkg every other day for at least 4 weeks or equivalent dosing of alternate corticosteroids without complete resolution of signs and symptoms 